Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NSPR
NSPR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NSPR News
InspireMD Reports Q1 2026 Earnings with 120% Revenue Growth Amid FDA Challenges
May 04 2026
seekingalpha
InspireMD Initiates New Trial and Recalls Product
May 01 2026
stocktwits
InspireMD Receives FDA Approval to Initiate CGUARDIANS III Trial
May 01 2026
Newsfilter
INSPIREMD INC - RECALL DUE TO CGUARD PRIME 135 CM TECHNICAL PERFORMANCE FALLING SHORT OF EXPECTATIONS
May 01 2026
moomoo
InspireMD to Announce Q1 Earnings on May 4th
May 01 2026
seekingalpha
Purcell & Lefkowitz LLP Investigates InspireMD for Potential Fiduciary Breaches
Apr 14 2026
PRnewswire
InspireMD Reports 62% Revenue Growth in Q4 2025 Driven by Seaguard Prime Launch
Mar 18 2026
Yahoo Finance
InspireMD Reports Q4 2025 Earnings with Strong Growth and Strategic Outlook
Mar 18 2026
seekingalpha
InspireMD Q4 Earnings Exceed Expectations
Mar 18 2026
seekingalpha
InspireMD to Announce Q4 Earnings on March 18
Mar 17 2026
seekingalpha
InspireMD to Release Q4 and Full Year 2025 Financial Results
Mar 09 2026
Newsfilter
InspireMD Publishes Positive CREST-2 Data Confirming Efficacy of Carotid Stenting
Nov 24 2025
Newsfilter
InspireMD to Attend the 37th Annual Healthcare Conference Hosted by Piper Sandler
Nov 19 2025
Newsfilter
InspireMD, Inc. Reports Wider Q3 Loss, Yet Surpasses Expectations
Nov 04 2025
NASDAQ.COM
InspireMD Names Peter Soukas as Chief Medical Officer
Nov 03 2025
NASDAQ.COM
Parkman Healthcare Increases Investment in InspireMD to Support Carotid Innovation
Sep 22 2025
Yahoo Finance
Show More News
